Difference between revisions of "Steroids"
m (→Introduction) |
|||
(40 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
− | + | Steroids are 21-carbon, 4-ring molecules, with biologically active steroids have a double covalent bond between carbon atoms 4 and 5, and a ketone group at C3. The body endogenously produces steroids which are essential for life; they regulate a variety of functions under normal physiological conditions and have important roles in response to stress. These steroids are produced in the [[Adrenal Glands - Anatomy & Physiology#Adrenal Glands|adrenal cortex]] and are therefore known as "corticosteroids". The corticosteroids can be further divided to [[Adrenal Glands - Anatomy & Physiology#Mineralocorticoids|mineralocorticoids]] and [[Adrenal Glands - Anatomy & Physiology#Glucocorticoids|glucocorticoids]] which are synthesised in different areas of the cortex. [[Adrenal Glands - Anatomy & Physiology#Mineralocorticoids|mineralocorticoids]] (such as aldosterone) are produced in the [[Adrenal Glands - Anatomy & Physiology#Adrenal Glands|zona glomerulosa]]; [[Adrenal Glands - Anatomy & Physiology#Glucocorticoids|glucocorticoids]] include cortisol (from the [[Adrenal Glands - Anatomy & Physiology#Adrenal Glands|zona fasiculata]]) and corticosterone (from the [[Adrenal Glands - Anatomy & Physiology#Adrenal Glands|zona reticularis]]). Corticosteroids are synthesised from plasma cholesterol which is stored in the adrenal gland and assimilated to corticosteroids as they are required. Endogenous glucocorticoid levels are regulated by the [[Adrenal Glands - Anatomy & Physiology#Glucocorticoids|hypothalamus-pituitary adrenal axis]], whereas the [[Important Hormonal Regulators of the Kidney - Anatomy & Physiology#The Renin Angiotensin Aldosterone System (RAAS)|renin angiotensin aldosterone system]] controls [[Adrenal Glands - Anatomy & Physiology#Mineralocorticoids|mineralocorticoid]] levels. | |
− | + | ||
− | + | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | Steroids are | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Line 18: | Line 11: | ||
==Actions== | ==Actions== | ||
− | Both endogenous and exogenous steroids have a variety of actions. Some of these, such as [[Steroids#Anti-Inflammatory Effects|anti-inflammatory effects]], are only seen at | + | Both endogenous and exogenous steroids have a variety of actions. Some of these, such as [[Steroids#Anti-Inflammatory Effects|anti-inflammatory effects]], are only seen at pharamacological concentrations. |
Alterations in steroid dose can influence the action they have. This is particulatly relevant to anti-inflammatory and immuno-suppressive effects. | Alterations in steroid dose can influence the action they have. This is particulatly relevant to anti-inflammatory and immuno-suppressive effects. | ||
Line 24: | Line 17: | ||
===Metabolic Effects=== | ===Metabolic Effects=== | ||
− | The metabolic effects of steroids are mainly catabolic and primarily | + | The metabolic effects of steroids are mainly catabolic and primarily effect carbohydrate and protein metabolism. They include: |
* Increasing gluconeogenesis, meaning amino acids and lactate are converted to glucose. | * Increasing gluconeogenesis, meaning amino acids and lactate are converted to glucose. | ||
Line 50: | Line 43: | ||
* '''Blood vessels''', to decrease vasodilation and fluid exudation. | * '''Blood vessels''', to decrease vasodilation and fluid exudation. | ||
* '''Inflammatory mediators''', by: | * '''Inflammatory mediators''', by: | ||
− | ** Inhibiting cyclo- | + | ** Inhibiting cyclo-oygenase, leading to a decrease in prostanoid levels. |
− | ** Inhibiting | + | ** Inhibiting phosphlipase-A2, reducing conversion of phospholipid to arachidonate and therfore mediator production. |
** Decreasing generation of inflammatory cytokines. | ** Decreasing generation of inflammatory cytokines. | ||
** Decreasing histamine release. | ** Decreasing histamine release. | ||
Line 65: | Line 58: | ||
===Immuno-Suppressive Effects=== | ===Immuno-Suppressive Effects=== | ||
− | Low doses of steroid inhibit the cellular response, decreasing lymphocytes, eosinophils, | + | Low doses of steroid inhibit the cellular response, decreasing lymphocytes, eosinophils, monocytes and basophils. However, neutrophil numbers are increased. High steroid doses inhibit the humoral response. |
==Pharmacokinetic Considerations== | ==Pharmacokinetic Considerations== | ||
Line 75: | Line 68: | ||
As with most drugs, steroids may be administered in a variety of ways. Topical steroids are appropriate for used in the eyes and ears, and on the skin. The structure of the drug can affect how useful it is topically; the C17 aliphatic side chain can influence topical absorption, and acetonide esters (e.g. betamethasone-17-valerate) are well absorbed from the skin but have little systemic access. Steroids are well absorbed orally, and may also be used parenterally, by inhalation and intra-articularly. | As with most drugs, steroids may be administered in a variety of ways. Topical steroids are appropriate for used in the eyes and ears, and on the skin. The structure of the drug can affect how useful it is topically; the C17 aliphatic side chain can influence topical absorption, and acetonide esters (e.g. betamethasone-17-valerate) are well absorbed from the skin but have little systemic access. Steroids are well absorbed orally, and may also be used parenterally, by inhalation and intra-articularly. | ||
− | ==Side Effects and Contraindications== | + | ==Side Effects and Contraindications== |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Drugs in This Group== | ==Drugs in This Group== | ||
− | |||
− | |||
− | |||
− | |||
{| border="1" cellpadding="7" | {| border="1" cellpadding="7" | ||
|-style="background:#B0E0E6; color:black" | |-style="background:#B0E0E6; color:black" | ||
Line 106: | Line 78: | ||
!'''Relative mineralocorticoid activity''' | !'''Relative mineralocorticoid activity''' | ||
!'''Duration of effect (hours)''' | !'''Duration of effect (hours)''' | ||
− | |- | + | |- |
− | | | + | |'''Hydrocortisone''' |
|1 | |1 | ||
|1 | |1 | ||
|8-12 | |8-12 | ||
|- style="background:#F0F8FF; color:black" | |- style="background:#F0F8FF; color:black" | ||
− | | | + | |'''Cortisone''' |
|0.8 | |0.8 | ||
|0.8 | |0.8 | ||
|8-12 | |8-12 | ||
− | |- | + | |- style="background:#B0E0E6; color:black" |
− | | | + | |'''Prednisolone''' |
|4 | |4 | ||
|0.8 | |0.8 | ||
|12-36 | |12-36 | ||
|- style="background:#F0F8FF; color:black" | |- style="background:#F0F8FF; color:black" | ||
− | | | + | |'''Prednisone''' |
|4 | |4 | ||
|0.8 | |0.8 | ||
|12-36 | |12-36 | ||
− | |- | + | |- style="background:#B0E0E6; color:black" |
− | | | + | |'''Methylprednisolone''' |
|5 | |5 | ||
|Minimal | |Minimal | ||
− | + | 12-36 | |
|- style="background:#F0F8FF; color:black" | |- style="background:#F0F8FF; color:black" | ||
− | | | + | |'''Dexamethasone''' |
− | |||
− | |||
− | |||
− | |||
− | |||
|30 | |30 | ||
|Minimal | |Minimal | ||
|24-28 | |24-28 | ||
− | |- style="background:# | + | |- style="background:#B0E0E6; color:black" |
− | | | + | |'''Betamethasone''' |
|30 | |30 | ||
|Minimal | |Minimal | ||
|24-48 | |24-48 | ||
− | |- | + | |- style="background:#F0F8FF; color:black" |
− | | | + | |'''Fludrocortisone''' |
|15 | |15 | ||
|150 | |150 | ||
|8-12 | |8-12 | ||
|} | |} | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Clinical Uses== | ==Clinical Uses== | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− |
Revision as of 16:52, 8 February 2009
Steroids are 21-carbon, 4-ring molecules, with biologically active steroids have a double covalent bond between carbon atoms 4 and 5, and a ketone group at C3. The body endogenously produces steroids which are essential for life; they regulate a variety of functions under normal physiological conditions and have important roles in response to stress. These steroids are produced in the adrenal cortex and are therefore known as "corticosteroids". The corticosteroids can be further divided to mineralocorticoids and glucocorticoids which are synthesised in different areas of the cortex. mineralocorticoids (such as aldosterone) are produced in the zona glomerulosa; glucocorticoids include cortisol (from the zona fasiculata) and corticosterone (from the zona reticularis). Corticosteroids are synthesised from plasma cholesterol which is stored in the adrenal gland and assimilated to corticosteroids as they are required. Endogenous glucocorticoid levels are regulated by the hypothalamus-pituitary adrenal axis, whereas the renin angiotensin aldosterone system controls mineralocorticoid levels.
Mechanism of Action
Steroids cross the cell membrane by diffusion and bind to a steroid-specific cytoplasmic receptor. The receptor-steroid complex then translocates to the nucleus and acts to up- or down-regulate expression of certain genes by increasing or decreasing the transcription of their mRNAs. Sometimes this action is linked to interaction of the complex with transcription activator protein, an enhancer of gene transcription.
Examples of genes which are induced by steroids are angiotensins convertins enzyme and the Beta2-adrenoceptor. Those inhibited include cytokines, cyclo-oxygenase and collagenase.
Actions
Both endogenous and exogenous steroids have a variety of actions. Some of these, such as anti-inflammatory effects, are only seen at pharamacological concentrations.
Alterations in steroid dose can influence the action they have. This is particulatly relevant to anti-inflammatory and immuno-suppressive effects.
Metabolic Effects
The metabolic effects of steroids are mainly catabolic and primarily effect carbohydrate and protein metabolism. They include:
- Increasing gluconeogenesis, meaning amino acids and lactate are converted to glucose.
- Inhibition of glucose utilisation, giving hyperglycaemia.
- Increasing glycogen storage. This occurs via insulin release in response to hyperglycaemia.
- Protein breakdown and reduced protein synthesis.
- Redistribution of body fat.
- Decreasing calcium absorption and enhancing calcium excretion.
Systemic Effects
The systemic effects of steroids include:
- Elevation of liver enzymes.
- Induction of abortion and parturition in ruminants. This effect is not noted in the dog or cat.
- Mineralocorticoid activities.
- Alteration of central nervous system function, although this is better described in human medicine.
Anti-Inflammatory Effects
Steroids only have anti-inflammatory actions at pharmacological concentrations. At physiological levels, these do not occur. Both early and late stages of inflammation are acted upon, and steroids affect all types of inflammatory reaction regardless of the inciting cause.
During the inflammatory response, pharmacological levels of steroids have an effect on:
- Blood vessels, to decrease vasodilation and fluid exudation.
- Inflammatory mediators, by:
- Inhibiting cyclo-oygenase, leading to a decrease in prostanoid levels.
- Inhibiting phosphlipase-A2, reducing conversion of phospholipid to arachidonate and therfore mediator production.
- Decreasing generation of inflammatory cytokines.
- Decreasing histamine release.
- Inflammatory cells. For example,
- Actions of helper T-cells are reduced.
- Accumulation of leucocytes in areas of inflammation is decreased.
- Macrophages are rendered less active in combating micro-organisms.
- Fibroblasts, to decrease their function and cause reduced healing and repair.
- Bone cells
- Osteoblast activity is reduced.
- Osteocalst activity is increased.
Immuno-Suppressive Effects
Low doses of steroid inhibit the cellular response, decreasing lymphocytes, eosinophils, monocytes and basophils. However, neutrophil numbers are increased. High steroid doses inhibit the humoral response.
Pharmacokinetic Considerations
Corticosteroids are highly plasma protein bound (around 90%). Binding may be both "generic" (to albumin) and "specific". Specific binding occurs to corticotrophin binding globulin (CBG), which has a high affinity but low capacity and hence binds endogenous corticosteroids only. Albumin binds both endogenous and synthetic steroids.
Corticosteroids have a short half-life, with that of cortisol being only 90 minutes. The drugs are metabolised in the liver, where the C4-5 double bind is reduced and conjugation with sulphate or glucuronic acid occurs. They are then excreted in the urine. Cortisone and prednisone are inactive prodrugs; upon liver metabolism they are converted to hydrocortisone and prednisolone respectively.
As with most drugs, steroids may be administered in a variety of ways. Topical steroids are appropriate for used in the eyes and ears, and on the skin. The structure of the drug can affect how useful it is topically; the C17 aliphatic side chain can influence topical absorption, and acetonide esters (e.g. betamethasone-17-valerate) are well absorbed from the skin but have little systemic access. Steroids are well absorbed orally, and may also be used parenterally, by inhalation and intra-articularly.
Side Effects and Contraindications
Drugs in This Group
Compound | Relative glucocorticoid activity | Relative mineralocorticoid activity | Duration of effect (hours) |
---|---|---|---|
Hydrocortisone | 1 | 1 | 8-12 |
Cortisone | 0.8 | 0.8 | 8-12 |
Prednisolone | 4 | 0.8 | 12-36 |
Prednisone | 4 | 0.8 | 12-36 |
Methylprednisolone | 5 | Minimal
12-36 | |
Dexamethasone | 30 | Minimal | 24-28 |
Betamethasone | 30 | Minimal | 24-48 |
Fludrocortisone | 15 | 150 | 8-12 |